A patient has benign prostatic hyperplasia (BPH) and will receive alfuzosin (Uroxatral). What is an important nursing action when administering this drug?

Question

Quizplus · Accepted Answer

Alfuzosin is indicated for BPH only and is contraindicated in patients with moderate to severe hepatic impairment; therefore, LFTs would be an important assessment. It does not interfere with ejaculation. It does not reduce blood pressure and does not cause sodium retention or increased blood volume, so diuretics are not necessary. It does not cause orthostatic hypotension, so first-dose effect precautions are not necessary.

A Patient Has Benign Prostatic Hyperplasia (BPH) and Will Receive